News | Ultrasound Women's Health | September 19, 2017

Philips Introduces New OB/GYN Ultrasound Innovations at ISUOG 2017

New anatomical intelligence, fingertip control and enhanced imaging versatility features for Philips' Epiq and Affiniti ultrasound systems offer clinicians optimized workflow and more information to evaluate pregnancies

Philips Introduces New OB/GYN Ultrasound Innovations at ISUOG 2017. Vivian Fornell

September 19, 2017 — Philips announced new OB/GYN innovations at the 27th World Congress on Ultrasound in Obstetrics and Gynecology (ISUOG), Sept. 16-19 in Vienna, Austria. New solutions include  aBiometry AssistA.I, TouchVue and Tilt, as well as the eL18-4 transducer available on Philips’ Epiq 7 and 5 and Affiniti 70 ultrasound systems. These OB/GYN ultrasound solutions are designed to give clinicians more information earlier in pregnancy, making it easier to provide a confident diagnosis and overcome diagnostic challenges. They feature innovations such as anatomical intelligence, fingertip control and enhanced imaging versatility. Philips also debuted its new InnoSight touch-screen based diagnostic compact ultrasound, which offers exceptional image quality and performance, according to the company.   

The portfolio of OB/GYN ultrasound tools being displayed at ISUOG 2017 includes:

  • aBiometry AssistA.I., with its anatomical intelligence of fetal anatomy that preplaces measurement cursors on selected structures, reducing conventional measurement steps to streamline fetal measurement and reporting workflow;
  • TrueVue with TouchVue interface, utilizes the Epiq touch panel, allowing users to intuitively interact and direct both the volume rotation and internal light source, creating photorealistic 3-D fetal images that allow deeper connection between the fetus and future parents;
  • Tilt maximizes OB/GYN imaging versatility with a new 2-D Tilt feature of the 3D9-v3 transducer, allowing for lateral scanning of anatomical structures that are off-axis without having to manually angle the transducer to provide more comfort to the patient;
  • The eL18-4 transducer features a multi-row array configuration for full electronic focusing of the elevation plan to provide imaging with exceptional detail resolution and tissue uniformity for clinical solutions including obstetrics; and
  • The new InnoSight diagnostic compact ultrasound system features an ergonomic, intuitive design and clinical versatility to meet the mobility needs across a wide range of applications.

aBiometry AssistA.I, TouchVue and Tilt, and the eL18-4 transducer are U.S. Food and Drug Administration (FDA) 510(k) pending and not yet available in the U.S.

These innovative features complement the existing suite of OB/GYN ultrasound visualization tools from Philips, which will also be on display: GlassVue transparent 3-D visualization with its internal light source, which provides an early, more transparent view of the fetal anatomy; aRevealA.I. Ultrasound (AIUS) 3-D fetal face algorithm that automatically removes extraneous information to quickly and easily reveal the 3-D fetal face; and MaxVue, which allows clinicians to experience ultrasound imaging in 16:9 full high definition (FHD).

“Philips' latest OB/GYN ultrasound offerings provide clinicians with the tools to deliver diagnostic confidence needed to provide the best care for patients,” said Michael Ruma, M.D., maternal-fetal medicine specialist at Perinatal Associates of New Mexico. “The beginning of a new life is a special time, and Philips’ solutions allow clinicians to focus on the needs of each expecting mother.”

For more information: www.usa.philips.com/healthcare

Related Content

Ultrasound-guided carpal tunnel release quickly improves hand function and reduces hand discomfort, making the procedure a safe, effective, and less invasive alternative to traditional open or endoscopic surgery

Patients answered three questionnaires (Quick-Disabilities of the Arm, Shoulder, and Hand [QDASH] and two parts of the Boston Carpal Tunnel Syndrome Questionnaire: symptom severity [BCTSQ-SS] and functional status [BCTSQ-FS] scales) assessing the affected wrist's function and discomfort immediately pre-procedure, 2 weeks post-procedure, and at least one year post-procedure. Infographic courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Ultrasound Imaging | September 17, 2020
September 17, 2020 — According to ARRS' American Journal of Roentgenology (AJR),...
Feature | Coronavirus (COVID-19) | September 15, 2020
September 15, 2020 — The world is facing a global pandemic with unknown implications, but it is now well known ...
Videos | Coronavirus (COVID-19) | September 15, 2020
Case is a 6-month-old infant boy admitted to hospital due to respiratory distress then worsened by a pericardial effu
The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.

The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.

News | Ultrasound Imaging | September 15, 2020
September 15, 2020 — Philips Healthcare recently introduced the latest addition to its portfolio of dedicated...
High-intensity focused ultrasound (HIFU), a technology used to treat localized prostate cancer, has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in The Journal of Urology, Official Journal of the American Urological Association

Getty Images

News | Prostate Cancer | September 08, 2020
September 8, 2020 — Approved by the US Food and Drug Administration (FDA) in 2015 for prostate tissue ablation, the h
Videos | Ultrasound Imaging | August 13, 2020
This is a tutorial video on how to perform an ...